AngioDynamics
ANGO
144 hedge funds and large institutions have $436M invested in AngioDynamics in 2025 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 55 increasing their positions, 47 reducing their positions, and 29 closing their positions.
734% more call options, than puts
Call options by funds: $1.91M | Put options by funds: $229K
19% more capital invested
Capital invested by funds: $366M → $436M (+$70.7M)
17% more repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 47
5.59% more ownership
Funds ownership: 90.69% → 96.28% (+5.6%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
4% less funds holding
Funds holding: 150 → 144 (-6)
21% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 29
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCMI
Paradigm Capital Management Inc
Albany,
New York
|
+$6.55M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$5.89M |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$4.84M |
| 4 |
Millennium Management
New York
|
+$3.8M |
| 5 |
BAM
Bastion Asset Management
Montreal,
Canada
|
+$2.94M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$4.71M |
| 2 |
YIH
Y-Intercept (HK)
Hong Kong
|
-$1.55M |
| 3 |
Renaissance Technologies
New York
|
-$1.25M |
| 4 |
Nuveen
Charlotte,
North Carolina
|
-$1.22M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.21M |
ANGO Hedge Fund Activity: Q3 2025 in Review
144 of the 7,640 institutional investors tracked by Wall St. Rank reported a position in AngioDynamics (ANGO) for Q3 2025, worth a combined $436M — up 19% from $366M a quarter earlier.
Sellers outnumbered buyers: 29 funds closed out of ANGO and 23 opened new positions — a net loss of 6 holders — while 47 trimmed existing stakes and 55 added.
The largest buyer was Paradigm Capital Management Inc, opening a new position worth an estimated $6.55M. The largest seller was AIGH Capital Management, exiting entirely with an estimated $4.71M sold.
- 144 institutional investors held AngioDynamics (ANGO) as of Q3 2025, down from 150 in Q2 2025.
- Funds reported $436M of AngioDynamics stock for Q3 2025, up 19% quarter-over-quarter.
- 23 funds opened new AngioDynamics positions in Q3 2025 and 29 closed out, a net change of -6 holders.
- The largest AngioDynamics buyer in Q3 2025 was Paradigm Capital Management Inc, an estimated $6.55M added.
- The largest AngioDynamics seller in Q3 2025 was AIGH Capital Management, an estimated $4.71M sold.
Based on aggregated 13F filings for Q3 2025.